A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2011
11/16/2011	CN102240292A 增强型比马前列素眼用溶液 Enhanced bimatoprost ophthalmic solution
11/16/2011	CN102240290A Pharmaceutical composition containing prulifloxacin, and preparation method thereof
11/16/2011	CN102240289A Pharmaceutical composition containing flibanserin polymorph a
11/16/2011	CN102240273A Preparation method of lansoprazole enteric capsules
11/16/2011	CN102240272A Potassium citrate sustained release tablet and preparation method thereof
11/16/2011	CN102240271A Lercanidipine hydrochloride dispersible tablets and preparation method thereof
11/16/2011	CN102240270A Blonanserin tablet and preparation method thereof
11/16/2011	CN102240269A Preparation method of crystalline clopidogrel bisulfate tablets
11/16/2011	CN102240268A Sustained/controlled release microsphere of biological extract Genipin cross-linked chitosan coated stilbene compound and preparation method thereof
11/16/2011	CN102240267A Folate-receptor-mediated pH-sensitive Decoy-ODN (Decoy-oligodeoxynucleotide) nanoparticle preparation and preparation method thereof
11/16/2011	CN102240265A Liposome vector system for tumor-targeted drug delivery
11/16/2011	CN102240263A Tiapride hydrochloride injection and preparation method thereof
11/16/2011	CN102240059A Method for preparing bacteriostat and application of acorn extract used as bacteriostat
11/16/2011	CN102240040A Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
11/16/2011	CN102239961A Flavoring agent
11/16/2011	CN102085266B Anti-erosive suppository for treating gynecological infection and preparation method thereof
11/16/2011	CN101933909B Vaccine adjuvant effervescent tablet and preparation method thereof
11/16/2011	CN101933904B Vinorelbine long circulation liposome preparation and preparation method thereof
11/16/2011	CN101919818B Method for preparing tetrandrine lung-targeted controlled-release microspheres
11/16/2011	CN101845120B Method for synthesizing temperature-sensitive and biodegradable in situ gel
11/16/2011	CN101785867B Preparation method of corn protein nano-particles
11/16/2011	CN101780036B Butyrate clevidipine lipid microsphere injection and preparation method thereof
11/16/2011	CN101732409B Salvia miltiorrhiza soft capsule and preparation method thereof
11/16/2011	CN101716198B Method for preparing total ginkgo flavone glycosides slow-release capsules by applying attapulgite
11/16/2011	CN101716186B Wound antibiotic flushing fluid and preparation method thereof
11/16/2011	CN101703483B Omeprazole sodium freeze-dried powder injection and preparation method thereof
11/16/2011	CN101665544B Chitosan grafting compound of cinnamic acid derivatives and application
11/16/2011	CN101649312B Human plasminogen K5 modified by RGD and preparation method and application thereof
11/16/2011	CN101638435B Blue-green algal virus protein N mutant, modified derivative and application thereof
11/16/2011	CN101627973B Calcium acetate tablet and preparation method thereof
11/16/2011	CN101612126B Preparation of immunoliposome of CD19 monoclonal antibody and application
11/16/2011	CN101543629B Application of papaverine hydrochloride as transdermal absorption enhancer
11/16/2011	CN101543563B Vein-relaxing bone-nourishing osteophyte-eliminating ointment and method for preparing same
11/16/2011	CN101541868B Process for production of porous body and uses thereof
11/16/2011	CN101507715B Solid preparation of angiotensin receptor inhibitor and amlodipine and new preparation method thereof
11/16/2011	CN101492539B Dichloro-platinum aspartate
11/16/2011	CN101489536B Process for producing spherical elementary granule containing readily water-soluble drug
11/16/2011	CN101406474B Nalmefene injection and preparation method thereof
11/16/2011	CN101401638B Method for preparing edible mushroom synbiotics microcapsule
11/16/2011	CN101395168B Galactose derivative,Drug carrier and medicinal composition
11/16/2011	CN101137364B Compositions comprising an epothilone and production methods
11/16/2011	CN101095942B Formulation of the Exendin injection medicine containing stabilizing agent
11/16/2011	CN101062040B Stable type cucurbitacin liquid formula and the agent thereof
11/16/2011	CN101043908B Complex containing mequitazine, a cyclodextrin and an interaction agent
11/16/2011	CN101005846B Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase
11/15/2011	US8058483 Phi/phi form; stabilizing such as vitamin C; shelf life
11/15/2011	US8058451 Enhanced solubility in common solvents; ion sensor; removal odors; water and air pollution control
11/15/2011	US8058344 Glycodendrimers having biological activity
11/15/2011	US8058304 Merged ion channel modulating compounds and uses thereof
11/15/2011	US8058267 Steroids as agonists for FXR
11/15/2011	US8058266 Methods and compositions for treatment of macular and retinal disease
11/15/2011	US8058249 Immunostimulatory nucleic acid molecules
11/15/2011	US8058226 a mixture of antihemophilic factor, bulking agent selected from mannitol, glycine and alanine, stabilizer agents selected from sucrose, trehalose, raffinose and arginine, calcium chloride, sodium chloride and buffers, having storage stability
11/15/2011	US8058068 Covalent coupled of nucleic acids, peptides or proteins to active material for enhancing transfection efficiency; potentiation
11/15/2011	US8057996 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
11/15/2011	US8057823 Lipid nanocapsules, preparation process and use as medicine
11/15/2011	US8057822 Modified exendins and exendin agonists
11/15/2011	US8057811 Stable clozapine suspension formulation
11/15/2011	US8057799 ErbB interface peptidomimetics and methods of use thereof
11/15/2011	CA2489188C Transdermal absorption preparation
11/15/2011	CA2480889C External preparation for wounds
11/15/2011	CA2476166C Anti-cd20 antibodies and fusion proteins thereof and methods of use
11/15/2011	CA2429979C Treatment of statin side effects
11/15/2011	CA2422031C Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
11/15/2011	CA2421791C Method for binding, in solution, a peptide and a lipophilic vector and uses thereof
11/15/2011	CA2410387C Polymerizable compositions and methods of use
11/15/2011	CA2318392C Mammalian appeasing pheromones to decrease stress, anxiety and aggressiveness
11/15/2011	CA2257851C Modulators of tissue regeneration
11/15/2011	CA2170641C Senescent cell-derived inhibitors of dna synthesis
11/12/2011	CA2703807A1 Enhanced stability of inverse thermal gelling composite hydrogels
11/10/2011	WO2011140519A2 In vivo gelling pharmaceutical pre-formulation
11/10/2011	WO2011140517A2 Methods for treating diseases of the lung
11/10/2011	WO2011140274A2 Method and device for transdermal delivery of parathyroid hormone using a microprojection array
11/10/2011	WO2011140236A2 Triamcinolone acetonide formulations for treating dermatitis and psoriasis
11/10/2011	WO2011139763A1 Methods and compositions for inducing satiety
11/10/2011	WO2011139718A1 Compositions and methods useful for reducing the viscosity of protein-containing formulations
11/10/2011	WO2011139420A2 Propynylaminoindan transdermal compositions
11/10/2011	WO2011139237A1 Composition for the treatment of helicobacter pylori (h. pylori) infectious
11/10/2011	WO2011139218A1 Nucleic acid delivery vehicle uses thereof
11/10/2011	WO2011139103A2 Method for producing a water-insoluble gel composition and a water-insoluble gel produced thereby
11/10/2011	WO2011139101A2 Method for producing the solid phase of a water-insoluble gel composition and a water-insoluble gel produced thereby
11/10/2011	WO2011139044A2 Controlled-release pharmaceutical composition including tamsulosin or the pharmaceutically acceptable salts thereof, and oral preparation including same
11/10/2011	WO2011138975A1 High density poly-alkylene glycol-coated iron oxide gold core-shell nanoparticle
11/10/2011	WO2011138973A1 Vitamin-containing nutrition infusion for administration through peripheral vein
11/10/2011	WO2011138801A1 Novel ophthalmic compositions
11/10/2011	WO2011138757A1 Peptide derivatives for biofunctionalization of silicon substrates and their applications
11/10/2011	WO2011138636A1 Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides
11/10/2011	WO2011138533A1 Novel self-reversible reverse latex, and use thereof as a thickening agent in a cosmetic composition
11/10/2011	WO2011138484A1 Aqueous pharmaceutical system for the administration of drugs to the nails
11/10/2011	WO2011138262A1 Topical pharmaceutical composition comprising heparin
11/10/2011	WO2011138155A1 Chitosan composition
11/10/2011	WO2011113000A8 Novel ester containing compositions and methods
11/10/2011	WO2011112996A3 Injectable drug delivery system
11/10/2011	WO2011107436A3 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation
11/10/2011	WO2011103150A3 Lyophilized preparations of bendamustine
11/10/2011	WO2011090305A3 Liquid formulations for long-acting g-csf conjugate
11/10/2011	WO2011086574A3 Formulations of nano-carriers and methods of preparing the same
11/10/2011	WO2011085298A3 Compositions comprising pigment particles entrapped in collapsed polymeric microspheres, and methods of making the same
11/10/2011	WO2011066390A3 Nanoscale adjuvants and related pharmaceutical compositions and methods
11/10/2011	WO2011066201A3 Methods and systems for treating and preventing cardiac injury in dystrophic subjects

1 ... 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 ... 1712